These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37014226)
1. Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al. Srinivasan K; Ho DY Antimicrob Agents Chemother; 2023 May; 67(5):e0027623. PubMed ID: 37014226 [No Abstract] [Full Text] [Related]
2. Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients. Bosetti D; Bernardi C; Maulini M; Giannotti F; Mamez AC; Masouridi-Levrat S; Chalandon Y; Neofytos D Antimicrob Agents Chemother; 2023 Apr; 67(4):e0173222. PubMed ID: 36971558 [TBL] [Abstract][Full Text] [Related]
3. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Ariza-Heredia EJ; Chemaly RF; Shahani LR; Jang Y; Champlin RE; Mulanovich VE Transpl Int; 2018 Jun; 31(6):639-648. PubMed ID: 29464765 [TBL] [Abstract][Full Text] [Related]
4. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533 [TBL] [Abstract][Full Text] [Related]
5. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [TBL] [Abstract][Full Text] [Related]
6. Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2. Cannon L; Tholouli E; Ward C; Farooq H; Kingston M Int J STD AIDS; 2021 Sep; 32(10):978-980. PubMed ID: 33947276 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Kim JH; Schaenman JM; Ho DY; Brown JM Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475 [TBL] [Abstract][Full Text] [Related]
8. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient. Muluneh B; Dean A; Armistead P; Khan T J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis. Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740 [TBL] [Abstract][Full Text] [Related]
10. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients. Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848 [TBL] [Abstract][Full Text] [Related]
11. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration. Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949 [TBL] [Abstract][Full Text] [Related]
12. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation. Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498 [No Abstract] [Full Text] [Related]
13. Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients. Anton-Vazquez V; Mehra V; Mbisa JL; Bradshaw D; Basu TN; Daly ML; Mufti GJ; Pagliuca A; Potter V; Zuckerman M J Clin Virol; 2020 Jul; 128():104421. PubMed ID: 32417677 [TBL] [Abstract][Full Text] [Related]
14. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives. Schalkwijk HH; Snoeck R; Andrei G Biochem Pharmacol; 2022 Dec; 206():115322. PubMed ID: 36309081 [TBL] [Abstract][Full Text] [Related]
15. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation. Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144 [TBL] [Abstract][Full Text] [Related]
16. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431 [TBL] [Abstract][Full Text] [Related]
17. Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections. Birkmann A; Bonsmann S; Kropeit D; Pfaff T; Rangaraju M; Sumner M; Timmler B; Zimmermann H; Buschmann H; Ruebsamen-Schaeff H J Med Chem; 2022 Oct; 65(20):13614-13628. PubMed ID: 36202389 [TBL] [Abstract][Full Text] [Related]